![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2018
Vries, Rory D. de; Altenburg, Arwen F.; Nieuwkoop, Nella J.; Bruin, Erwin de; Trierum, Stella E. van; Pronk, Mark R.; Lamers, Mart M.; Richard, Mathilde; Nieuwenhuijse, David F.; Koopmans, Marion P. G.; Kreijtz, Joost H. C. M.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Sutter, Gerd 
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2018):
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
In: Journal of Infectious Diseases, Bd. 218, Nr. 4: S. 614-623
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2018):
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
In: Journal of Infectious Diseases, Bd. 218, Nr. 4: S. 614-623
2016
Haagmans, Bart L.; Brand, Judith M. A. van den; Raj, V. Stalin; Volz, Asisa; Wohlsein, Peter; Smits, Saskia L.; Schipper, Debby; Bestebroer, Theo M.; Okba, Nisreen; Fux, Robert; Bensaid, Albert; Foz, David Solanes; Kuiken, Thijs; Baumgärtner, Wolfgang; Segalés, Joaquim; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X und Osterhaus, Albert D. M. E.
(2016):
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.
In: Science, Bd. 351, Nr. 6268: S. 77-81
ORCID: https://orcid.org/0000-0001-6143-082X und Osterhaus, Albert D. M. E.
(2016):
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.
In: Science, Bd. 351, Nr. 6268: S. 77-81
Volz, Asisa; Lim, Stephanie; Kaserer, Martina; Lülf, Anna; Marr, Lisa; Jany, Sylvia; Deeg, Cornelia A.; Pijlman, Gorben P.; Koraka, Penelope; Osterhaus, Albert D. M. E.; Martina, Byron E. und Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X
(2016):
Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
In: Vaccine, Bd. 34, Nr. 16: S. 1915-1926
ORCID: https://orcid.org/0000-0001-6143-082X
(2016):
Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
In: Vaccine, Bd. 34, Nr. 16: S. 1915-1926
2014
Doel, Petra van den; Volz, Asisa; Roose, Jouke M.; Sewbalaksing, Varsha D.; Pijlman, Gorben P.; Middelkoop, Ingeborg van; Duiverman, Vincent; de Wetering, Eva van; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X; Osterhaus, Albert D. M. E. und Martina, Byron E. E.
(2014):
Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge.
In: PLOS Neglected Tropical Diseases 8(9), e3101 [PDF, 1MB]
ORCID: https://orcid.org/0000-0001-6143-082X; Osterhaus, Albert D. M. E. und Martina, Byron E. E.
(2014):
Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge.
In: PLOS Neglected Tropical Diseases 8(9), e3101 [PDF, 1MB]
2009
Kreijtz, Joost H. C. M.; Suezer, Yasemin; Mutsert, Gerrie de; Amerongen, Geert van; Schwantes, Astrid; Brand, Judith M. A. van den; Fouchier, Ron A. M.; Löwer, Johannes; Osterhaus, Albert D. M. E.; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2009):
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
In: PLOS ONE 4(11), e7790 [PDF, 925kB]
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2009):
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
In: PLOS ONE 4(11), e7790 [PDF, 925kB]